Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal InfectionsJohn R. Perfect, Elizabeth M. Johnson, Kieren A. Marr et al.|Clinical Infectious Diseases|2003Cited by 680
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environmentJohanna Rhodes, Matthew C. Fisher, Eloise Ballard et al.|Nature Microbiology|2022Cited by 245
Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.David W. Warnock, Thomas R. Rogers, Elizabeth M. Johnson|Journal of Antimicrobial Chemotherapy|1998Cited by 58
A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unitAlida Fe Talento, Thomas R. Rogers, Katie Dunne et al.|Journal of Critical Care|2017Cited by 34
Topical antifungal treatments for tinea cruris and tinea corporisMagdy El-Gohary, Paul Little, Hana Burgess et al.|Cochrane Database of Systematic Reviews|2012Cited by 34